Kringle Pharma, Inc. (TYO:4884)
Japan
· Delayed Price · Currency is JPY 859.00
-19.00 (-2.16%)
Jun 6, 2025, 3:30 PM JST
Kringle Pharma Market Cap
Kringle Pharma has a market cap or net worth of 5.87 billion as of June 6, 2025. Its market cap has increased by 48.45% in one year.
Market Cap
5.87B
Enterprise Value
3.99B
Revenue
72.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
859.00
Market Cap Chart
Since December 28, 2020, Kringle Pharma's market cap has increased from 5.09B to 5.87B, an increase of 15.48%. That is a compound annual growth rate of 3.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 5.87B | -1.22% |
| Dec 30, 2024 | 5.95B | 30.66% |
| Dec 29, 2023 | 4.55B | 47.85% |
| Dec 30, 2022 | 3.08B | -0.04% |
| Dec 30, 2021 | 3.08B | -45.04% |
| Dec 30, 2020 | 5.60B | 10.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.54T |
| Takeda Pharmaceutical Company | 6,708.09B |
| Daiichi Sankyo Company | 6,505.29B |
| HOYA Corporation | 5,646.72B |
| Terumo | 3,842.99B |
| Otsuka Holdings | 3,579.13B |
| Astellas Pharma | 2,498.99B |
| Olympus | 2,199.23B |